Analyses of First plus Recurrent Cardiovascular and Hospitalization Events in the Cardiovascular and Renal Microvascular Outcome Study with Linagliptin (CARMELINA) in Patients with Type 2 Diabetes and Cardiorenal Disease

被引：1
|
作者：
Marx, Nikolaus
Mcguire, Darren K.
Johansen, Odd Erik
Rosenstock, Julio
Kahn, Steven E.
Cooper, Mark E.
Toto, Robert D.
Wanner, Christoph
Pfarr, Egon
Schnaidt, Sven
George, Jyothis
Von Eynatten, Maximilian
Perkovic, Vlado
Zinman, Bernard
Alexander, John H.
机构：
来源：
DIABETES | 2019年 / 68卷
关键词：
D O I：
10.2337/db19-432-P
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
432-P
引用
收藏
页数：3
相关论文
共 50 条
  • [1] First plus recurrent CV and hospitalization events in the CArdiovascular and Renal Microvascular outcomE study with LINAgliptin (CARMELINA) in patients with type 2 diabetes and cardiorenal disease
    Marx, N.
    McGuire, D. K.
    Johansen, O.
    Rosenstock, J.
    Kahn, S. E.
    Cooper, M. E.
    Toto, R.
    Wanner, C.
    Pfarr, E.
    Schnaidt, S. Y.
    George, J. T.
    Von Eynatten, M.
    Perkovic, V.
    Zinman, B.
    Alexander, J. A.
    EUROPEAN HEART JOURNAL, 2019, 40 : 3877 - 3877
  • [2] CARMELINA® trial baseline characteristics: a cardiovascular and renal microvascular outcome trial with linagliptin in patients with type 2 diabetes at high vascular risk
    Perkovic, V.
    Rosenstock, J.
    MacGuire, D. K.
    DIABETOLOGIA, 2017, 60 : S357 - S357
  • [3] CARMELINA® Trial Baseline Characteristics: A Cardiovascular and Renal Microvascular Outcome Trial with Linagliptin in Patients with Type 2 Diabetes at High Vascular Risk
    Rosenstock, Julio
    Perkovic, Vlado
    Alexander, John H.
    Cooper, Mark Emmanuel
    Kahn, Steven E.
    Marx, Nikolaus
    Pencina, Michael J.
    Toto, Robert D.
    Wanner, Christoph
    Zinman, Bernard
    Baanstra, David
    Pfarr, Egon
    Mattheus, Michaela
    George, Jyothis T.
    Broedl, Uli C.
    Woerle, Hans-Juergen
    Von Eynatten, Maximilian
    Mcguire, Darren K.
    DIABETES, 2017, 66 : A344 - A344
  • [4] Analyses of First Plus Recurrent Cardiovascular (CV) and Hospitalization Events in the CAROLINA Trial
    Marx, Nikolaus
    McGuire, Darren K.
    Johansen, Odd Erik
    Rosenstock, Julio
    Pfarr, Egon
    Mattheus, Michaela
    George, Jyothis T.
    Espeland, Mark
    Zinman, Bernard
    DIABETES, 2020, 69
  • [5] Linagliptin and cardiorenal outcomes in Asians with type 2 diabetes mellitus and established cardiovascular and/or kidney disease: subgroup analysis of the randomized CARMELINA® trial
    Nobuya Inagaki
    Wenying Yang
    Hirotaka Watada
    Linong Ji
    Sven Schnaidt
    Egon Pfarr
    Tomoo Okamura
    Odd Erik Johansen
    Jyothis T. George
    Maximilian von Eynatten
    Julio Rosenstock
    Vlado Perkovic
    Christoph Wanner
    Mark E. Cooper
    John H. Alexander
    Issei Komuro
    Masaomi Nangaku
    Diabetology International, 2020, 11 : 129 - 141
  • [6] Linagliptin and cardiorenal outcomes in Asians with type 2 diabetes mellitus and established cardiovascular and/or kidney disease: subgroup analysis of the randomized CARMELINA® trial
    Inagaki, Nobuya
    Yang, Wenying
    Watada, Hirotaka
    Ji, Linong
    Schnaidt, Sven
    Pfarr, Egon
    Okamura, Tomoo
    Johansen, Odd Erik
    George, Jyothis T.
    von Eynatten, Maximilian
    Rosenstock, Julio
    Perkovic, Vlado
    Wanner, Christoph
    Cooper, Mark E.
    Alexander, John H.
    Komuro, Issei
    Nangaku, Masaomi
    DIABETOLOGY INTERNATIONAL, 2020, 11 (02) : 129 - 141
  • [7] Effect of Linagliptin vs Placebo on Major Cardiovascular Events in Adults With Type 2 Diabetes and High Cardiovascular and Renal Risk The CARMELINA Randomized Clinical Trial
    Rosenstock, Julio
    Perkovic, Vlado
    Johansen, Odd Erik
    Cooper, Mark E.
    Kahn, Steven E.
    Marx, Nikolaus
    Alexander, John H.
    Pencina, Michael
    Toto, Robert D.
    Wanner, Christoph
    Zinman, Bernard
    Woerle, Hans Juergen
    Baanstra, David
    Pfarr, Egon
    Schnaidt, Sven
    Meinicke, Thomas
    George, Jyothis T.
    von Eynatten, Maximilian
    McGuire, Darren K.
    Aizenberg, D.
    Fiorella, A.
    Edgardo, N.
    Belen, C. Ianina
    Alonso, P.
    Walter, M.
    Maia, K.
    Guillermo, S.
    Leandro, B.
    Constanza, R. M.
    Alejandra, N. M.
    Melina, C.
    Ariel, I. L.
    Martin, S.
    Rodrigo, C.
    Alvarez, C.
    Jorge, M. Z.
    Gabriel, C.
    German, S.
    Bartolacci, I.
    Bolobanich, G. A.
    Tale, T.
    Meritano, M.
    Echeverria, M. G.
    Gerrini, S. P.
    Alvarez, M. R. y
    Torrijos, N.
    Berli, M.
    Coggiola, J.
    Castaneda, G.
    Rode, R.
    JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2019, 321 (01): : 69 - 79
  • [8] Linagliptin in patients with type 2 diabetes and cardiovascular and/or renal disease: results from a cardiovascular and renal outcomes trial
    Guthrie, Robert
    POSTGRADUATE MEDICINE, 2020, 132 (04) : 314 - 319
  • [9] Influence of Microvascular Disease on Cardiovascular Events in Type 2 Diabetes
    Verma, Subodh
    Wanner, Christoph
    Zwiener, Isabella
    Ofstad, Anne Pernille
    George, Jyothis T.
    Fitchett, David
    Zinman, Bernard
    Aizenberg, D.
    Ulla, M.
    Waitman, J.
    De Loredo, L.
    Farias, J.
    Fideleff, H.
    Lagrutta, M.
    Maldonado, N.
    Colombo, H.
    Ferre Pacora, F.
    Wasserman, A.
    Maffei, L.
    Lehman, R.
    Selvanayagam, J.
    d'Emden, M.
    Fasching, P.
    Paulweber, B.
    Toplak, H.
    Luger, A.
    Drexel, H.
    Prager, R.
    Schnack, C.
    Schernthaner, G.
    Fliesser-Goerzer, E.
    Kaser, S.
    Scheen, A.
    Van Gaal, L.
    Hollanders, G.
    Kockaerts, Y.
    Capiau, L.
    Chachati, A.
    Persu, A.
    Hermans, M.
    Vantroyen, D.
    Vercammen, C.
    Van de Borne, P.
    Mathieu, C.
    Benhalima, K.
    Lienart, F.
    Mortelmans, J.
    Strivay, M.
    Vereecken, G.
    Keymeulen, B.
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2019, 73 (21) : 2780 - 2782
  • [10] Recurrent Cardiovascular Events in Patients with Type 2 Diabetes after Hospitalization for Acute Coronary Syndrome: The Fremantle Diabetes Study
    Davis, Wendy A.
    Davis, Timothy M. E.
    DIABETES, 2015, 64 : A679 - A679
12345